,sentence,pubmed_id,content,label,labeler
0,2 |||  ||| 0.2 ||| This prospective and randomized study evaluates the efficacy and safety of pre-and periopera-tive IABC in high-risk OPCAB.,12869172,evaluates the efficacy and safety of pre-and periopera-tive IABC in high-risk OPCAB,pr.Disease,lingtaiwei
1,4 |||  ||| 0.4 ||| Adult high-risk coronary patients to undergo OPCAB.,12869172,Adult ,po.Age,lingtaiwei
2,"24 ||| Study design ||| 2.6 ||| Definition of high risks: Any CAD patient presenting with a minimum of two of the following objective preoperative criteria and planned for OPCAB revascularization was enrolled in this study: Left ventricular dysfunction, left ventricular ejection fraction (LVEF) equal or less than 0.30, re-operative CABG (or previous cardiac operation), preoperative unstable angina despite optimal medical treatment (including nitroglycerin and heparin therapy), left coronary main stem stenosis greater than 70%, and recent myocardial infarction less than 10 days prior to surgery (Table 1).",12869172,"Definition of high risks: Any CAD patient presenting with a minimum of two of the following objective preoperative criteria and planned for OPCAB revascularization was enrolled in this study: Left ventricular dysfunction, left ventricular ejection fraction (LVEF) equal or less than 0.30, re-operative CABG (or previous cardiac operation), preoperative unstable angina despite optimal medical treatment (including nitroglycerin and heparin therapy), left coronary main stem stenosis greater than 70%, and recent myocardial infarction less than 10 days prior to surgery (Table 1).",po.Disease,lingtaiwei
3,3 |||  ||| 0.3 ||| Material: Group A-IABC started prior to induction of anesthesia (n = 15); group B-no preoperative IABC (n = 15).,12869172,Group A-IABC started prior to induction of anesthesia (n = 15); group B-no preoperative IABC (n = 15).,i.Procedure,lingtaiwei
4,"25 ||| Study design ||| 2.7 ||| Patients fulfilling the inclusion criteria were randomly allocated to either of two treatment paths: Group A-therapy group-preoperative IABC therapy, started prior to induction of anesthesia, followed by continuous IABC during the entire procedure as well as postoperatively.",12869172,"Group A-therapy group-preoperative IABC therapy, started prior to induction of anesthesia, followed by continuous IABC during the entire procedure as well as postoperatively.",i.Procedure,lingtaiwei
5,"17 |||  ||| 0.17 ||| Conclusions: Pre-and perioperative IABC therapy offers efficient hemodynamic support during high-risk OPCAB surgery, lowers the risk of hemodynamic instability, is safe and shortens both ICU and hospital length of stay significantly, and is a cost-effective therapy.",12869172,"Pre-and perioperative IABC therapy offers efficient hemodynamic support during high-risk OPCAB surgery, lowers the risk of hemodynamic instability, is safe and shortens both ICU and hospital length of stay significantly, and is a cost-effective therapy",o.Treatment,lingtaiwei
6,105 ||| DISCUSSION ||| 6.7 ||| Earlier reports have shown that use of preoperative IABC therapy can reduce myocardial ischemia and therefore improve outcome in high-risk patients undergoing CABG with the use of CPB.,12869172,reduce myocardial ischemia and therefore improve outcome in high-risk patients undergoing CABG with the use of CPB,O,lingtaiwei
7,"112 ||| DISCUSSION ||| 6.14 ||| In the present prospective randomized study, we have clearly demonstrated that pre-and perioperative IABC therapy is an efficient and safe supportive modality which significantly decreases the risk for hemodynamic instability and conversion in high-risk coronary patients undergoEarlier reports on high balloon-related complication rates have dissuaded surgeons from preventive use of IABC.",12869172, pre-and perioperative IABC therapy is an efficient and safe supportive modality,O,lingtaiwei
